Terms: = Gastric cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4
29598 results:
1. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
2. Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer.
Liu T; Ma Y; Han S; Sun P
J Cancer Res Clin Oncol; 2024 May; 150(5):261. PubMed ID: 38761291
[TBL] [Abstract] [Full Text] [Related]
3. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
4. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
[TBL] [Abstract] [Full Text] [Related]
5. Hyponutrition among newly diagnosed gastric cancer.
Pham VT; Nguyen MLT; Pham C; LE QV; Tran DH; LE TS; Nguyen LT; Bui KC
Bratisl Lek Listy; 2024; 125(6):392-398. PubMed ID: 38757598
[TBL] [Abstract] [Full Text] [Related]
6. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
[TBL] [Abstract] [Full Text] [Related]
7. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants.
De la Torre K; Song M; Abe SK; Rahman MS; Islam MR; Saito E; Min S; Huang D; Chen Y; Gupta PC; Sawada N; Tamakoshi A; Shu XO; Wen W; Sakata R; Kim J; Nagata C; Ito H; Park SK; Shin MH; Pednekar MS; Tsugane S; Kimura T; Gao YT; Cai H; Wada K; Oze I; Shin A; Ahn YO; Ahsan H; Boffetta P; Chia KS; Matsuo K; Qiao YL; Rothman N; Zheng W; Inoue M; Kang D
J Diabetes; 2024 Jun; 16(6):e13561. PubMed ID: 38751364
[TBL] [Abstract] [Full Text] [Related]
8. Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data.
Egebjerg K; Andersen TS; Bæksgaard L; Garbyal R; Siemsen M; Achiam M; Mau-Sørensen PM
Acta Oncol; 2024 May; 63():322-329. PubMed ID: 38745482
[TBL] [Abstract] [Full Text] [Related]
9. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
10. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
Pang H; Dai L; Chen L; Chen X; Chen Z; Zhang S; Sun H
BMC Cancer; 2024 May; 24(1):583. PubMed ID: 38741082
[TBL] [Abstract] [Full Text] [Related]
12. Feasibility of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor with tumor diameter of >5 cm.
Iwakawa Y; Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Noma T; Shimada M
J Med Invest; 2024; 71(1.2):148-153. PubMed ID: 38735711
[TBL] [Abstract] [Full Text] [Related]
13. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
[TBL] [Abstract] [Full Text] [Related]
14. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
15. Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
Guchelaar NAD; Nasserinejad K; Mostert B; Koolen SLW; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Mathijssen RHJ; Noordman BJ
Br J Surg; 2024 May; 111(5):. PubMed ID: 38722803
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma.
Chang HY; Dermawan JK; Kuba MG; Crago AM; Singer S; Tap W; Chi P; D'Angelo S; Rosenbaum E; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23240. PubMed ID: 38722225
[TBL] [Abstract] [Full Text] [Related]
17. Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.
Seckinger A; Buatois V; Moine V; Daubeuf B; Richard F; Chatel L; Viandier A; Bosson N; Rousset E; Masternak K; Salgado-Pires S; Batista C; Mougin C; Juan-Bégeot F; Poitevin Y; Hose D
Front Immunol; 2024; 15():1378813. PubMed ID: 38720892
[TBL] [Abstract] [Full Text] [Related]
18. The effect of self-designed metabolic equivalent exercises on cancer-related fatigue in patients with gastric cancer: A randomized controlled trial.
Xin X; Huang L; Pan Q; Zhang J; Hu W
Cancer Med; 2024 May; 13(9):e7085. PubMed ID: 38716637
[TBL] [Abstract] [Full Text] [Related]
19. Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
Xie D; Shen J; Liu L; Cao B; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Gong J
Br J Surg; 2024 May; 111(5):. PubMed ID: 38713611
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
[Next]
